Anesthesia Intraoral Module (AIM)
The minimally invasive but often painful NORA (Non-Operating Room Anesthesia) procedures require deeper sedation with a potential for respiratory depression. It is time to move past the limitations of Face masks & Nasal cannulas.
AIM delivers oxygen and captures exhaled carbon dioxide for capnography in patients undergoing clinical procedures and require monitoring, per the safety guidelines of the American Society of Anesthesiologists (ASA).
Disclaimer: AIM is currently undergoing a review by the FDA and has not yet been approved for patient use.
How is AIM used?
AIM is placed between the teeth of the upper and lower jaw. Oxygen and capnography ports on AIM are connected to the oxygen supply outlet and the capnography monitor.
96% and Higher Oxygen Delivery
AIM’s innovative oxygen delivery closer to the tracheal inlet allows FiO2 of 96% and higher. The efficient system uses significantly less oxygen, providing additional value when oxygen conservation is essential (portable oxygen tanks).
A third-party lab in California tested AIM to collect data for FDA 510(k) submission. In a side-by-side comparison with the POM oxygen mask, the oxygen sensor at the simulated patient’s trachea captured 96% FiO2 with AIM, and only 58% with the POM mask.
Improved Capnography
Face mask capnography uses highly diluted CO2 as exhaled air mixes with the dead-space air and O2 flowing inside the mask. The washed-out capnography waveforms may be hard to differentiate from those of a hypoventilating patient.
AIM’s capnography port captures exhaled CO2 closer to the trachea with well-defined EtCO2 waveforms. An early alert and increased reaction time in a hypoventilating patient can avoid a catastrophic situation, particularly in remote hospital locations.
Single-Step Oral Airway Placement
Oral airway placement for upper airway obstruction is a time-consuming, multi-step process (remove face mask, pry the jaw open of a sedated, often uncooperative patient, place oral airway, replace face mask).
With AIM in place, oral airway insertion is a single step, minimizing procedural interruptions and delays.
Seamless Conversion to General Anesthesia
Emergent conversion to general anesthesia occurs secondary to excessive patient movement, extreme discomfort, or respiratory failure.
With an open oral cavity and O2 flowing into the oro-pharynx, AIM replaces the rushed and injury-prone maneuvers with a single-step conversion to general anesthesia.
Eliminates Bite-blocks
EGD and TEE bite-blocks and awake fiber-optic intubation (pink) airways are not needed, saving resources and contaminated medical waste disposal.
May Lower the Risk of Airway Fires
Nasal cannulas and face masks accumulate oxygen around a patient’s face (oxygen is heavier than air), risking airway fires, patient injuries, and malpractice lawsuits.
AIM’s oxygen delivery into the oro-pharynx may help reduce the risk of airway fires.
Small Size, Big Impact
Despite its small size compared to a face mask, AIM’s high oxygen delivery, accurate capnography, single-step airway resuscitation, seamless conversion to general anesthesia, and patient comfort could make it a suitable device for a wide range of NORA procedures.
Lower Environmental Impact
AIM consumes fewer manufacturing resources due to its compact size.
Additionally, by eliminating the need for EGD and TEE bite-blocks and awake fiberoptic intubation (pink) airways, AIM further lowers disposable consumption.
Manufactured in the USA
With a focus on manufacturing the highest quality medical device, everything from collaborating on the design, device molds, sourcing raw materials, manufacturing, parts assembly, and packaging is done here in the US. No overseas containers, and no supply chain issues.
